Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2024

Oncology drug development: Biotech status and prospects

The Academia perspective

Date

26 Feb 2024

Session

Oncology drug development: Biotech status and prospects

Topics

Clinical Research

Tumour Site

Presenters

Christophe Le Tourneau

Authors

C. Le Tourneau

Author affiliations

  • Department Of Drug Development And Innovation (d3i), Institut Curie, 75005 - Paris/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction

Presenter: Giovanni Abbadessa

Session: Oncology drug development: Biotech status and prospects

Resources:

Slides

Webcast

Panel discussion

Presenter: All Speakers

Session: Oncology drug development: Biotech status and prospects

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.